
Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. (TMCI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TMCI · as of Jun 8, 2026
Key Statistics
Explore Treace Medical Concepts, Inc. Data
tmci stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 22.2%
The TMCI analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $3.00, representing -15.01% downside from the current price of $3.53.
Competitors & Peers
tmci competitorsStock Performance
Full HistoryAbout Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. Headquartered in Ponte Vedra Beach, Florida, Treace Medical Concepts, Inc. is an orthopedic medical device enterprise that specializes in the development, manufacturing, and commercialization of surgi…
what is treace medical concepts, inc. · tmci stock overview · treace medical concepts, inc. company profile · who is treace medical concepts, inc. ceo · tmci NASDAQ · treace medical concepts, inc. headquarters · treace medical concepts, inc. business segments
About Stock Overview & Key Data
Treace Medical Concepts, Inc. (TMCI) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Apr 23, 2021. As of the latest trading session, TMCI stock price is $3.53, with a market capitalization of $229.0M. The stock has returned -39.41% over the past 12 months and +45.92% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Treace Medical Concepts, Inc. stock is Hold, with an average 12-month price target of $3.00. In fiscal year 2025, Treace Medical Concepts, Inc. reported revenue of $212.7M and net income of -$59.0M. For detailed data — including Treace Medical Concepts, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Treace Medical Concepts, Inc. (TMCI) stock price is $3.53. The stock is traded on NASDAQ under the ticker symbol TMCI. The 52-week range is $1.17 – $7.78.